Clincosm LogoSign in Get a demo

Effect of Interactive Tailored Assessment on Patient-provider Communication

Sponsor
Oslo University Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT00857103
Collaborator
The Research Council of Norway (Other)
200
Enrollment
1
Location
2
Arms
34
Duration (Months)
5.9
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

This interdisciplinary international research collaboration will test effects of Choice, a computer-assisted, interactive support system designed to help cancer patients communicate their symptoms and preferences, and clinicians in incorporating this information into patient care. In this pretest-post test clinical trial with 200 leukemia and lymphoma patients we will: 1) Test effects of Choice when integrated into routine clinical practice on: patient-provider communication, documented patient care, anxiety and patient satisfaction; 2) analyze relationships among the above variables and explore differences in these relationships between groups; 3) analyze group differences in communication style in terms of instrumental and affective behavior, content, participation, initiative and person addressed; and 4) investigate the extent of the time requirements when using Choice in clinical practice, perceived usefulness and ease of use.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: CHOICE
 N/A

Detailed Description

Improving shared decision making (SDM), patient-provider communication and incorporating patients' illness experiences and preferences into patient care are high priority health policy goals. However, this is difficult to accomplish without methods and systems that assist patients in sharing their illness experiences and clinicians in integrating this information into patient care. Choice is a computer-assisted, interactive communication and support system for cancer patients designed for this purpose. This interdisciplinary, international research collaboration will test effects of Choice in a pretest-post test clinical trial with 200 leukemia and lymphoma patients. We hypothesize that when patients use Choice for symptom and preference assessments and this information is provided to their clinicians to support consultations in routine practice, (1) patient-provider communication will be more patient-centered; (2) documented care will be more congruent with patients' reported symptoms and preferences; (3) patients will experience lower levels of anxiety and stress during consultations; and (4) they will be more satisfied with the consultation than the "usual care" control group. To better understand the mechanisms by which these effects occur, we will investigate relationships between communication style, documented patient care, anxiety and satisfaction; and explore time requirements, perceived usefulness and ease of use of Choice by patients and clinicians. Controlling for gender, age, diagnosis and type/stage of treatment, analyses of covariance and repeated measurement models will be primarily used for hypotheses testing, correlations and descriptive statistics to answer research questions. This study will contribute to new technologies to support SDM and patient-provider partnerships in health care that can significantly improve patient-provider communication, patient-centered care and physical, emotional and psycho-social well-being of cancer patients.

Study Design

Study Type:
Interventional
Actual Enrollment :
200 participants
Allocation:
Non-Randomized
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Improving Patient-Provider Communication in Cancer Care
Study Start Date :
Aug 1, 2006
Actual Primary Completion Date :
Jun 1, 2009
Actual Study Completion Date :
Jun 1, 2009

Arms and Interventions

Arm Intervention/Treatment
No Intervention: 1

Standard care
Experimental: 2

Use of Choice intervention to support consultations

Behavioral: CHOICE
Use of Choice support system as preparation for patient consultations
Other Names:
  • Standard care

    		•

    Outcome Measures

    Primary Outcome Measures

    1. Patient satisfaction [one point assessment]

    2. Anxiety [one point assessment]

    3. communication [one point assessment]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    • Diagnosed with leukemia or lymphoma and in treatment or follow up after treatment within last 12 months.

    • Being able to understand, speak and write Norwegian.

    • Informed consent

    Exclusion Criteria:
    • If clinician know patient will receive bad news regarding outcome.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Rikshospitalet University Hospital Oslo Norway 0027

    Sponsors and Collaborators

    • Oslo University Hospital
    • The Research Council of Norway

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Oslo University Hospital
    ClinicalTrials.gov Identifier:
    NCT00857103
    Other Study ID Numbers:
    • RCN 177500/V50
    First Posted:
    Mar 6, 2009
    Last Update Posted:
    Jun 17, 2013
    Last Verified:
    Jun 1, 2013
    Keywords provided by Oslo University Hospital
    computer support
    patient-provider communication
    patient-centered care
    cancer

    Study Results

    No Results Posted as of Jun 17, 2013